PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
114,114-009,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",36,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-019,T1,"MVA/HIV62B mo(0,4) post HVTN 205 MMM",33,Female,Black/African American,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-020,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",41,Male,Black/African American,No,,,,No,Scheduled exit visit/end of study,No,1
114,114-024,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",31,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-033,T1,"MVA/HIV62B mo(0,4) post HVTN 205 MMM",30,Male,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-034,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",27,Female,Black/African American,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-040,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",35,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-042,T2,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 MMM",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-048,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",36,Female,White,No,,,,Yes,Unable to contact participant,No,2
114,114-054,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",43,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-057,T1,"MVA/HIV62B mo(0,4) post HVTN 205 MMM",37,Female,White,No,Yes,Refused,,Yes,Participant refused further participantion,No,1
114,114-060,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",31,Male,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-062,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",31,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-064,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",38,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-065,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",28,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-066,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",39,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-067,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",26,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-069,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",26,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-078,T2,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 MMM",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-082,T2,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 MMM",28,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-083,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",25,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-084,T2,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 MMM",35,Male,Multiracial,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,1
114,114-085,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",54,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2
114,114-090,T3,"MVA/HIV62B mo(0,4) post HVTN 205 DDMM",33,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-091,T1,"MVA/HIV62B mo(0,4) post HVTN 205 MMM",29,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-094,T4,"MVA/HIV62B + AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
114,114-095,T5,"AIDSVAX B/E mo(0,4) post HVTN 205 DDMM",33,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,2